EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieMultizentrische StudieOpen Access · CC BY 4.0

Outcomes of native or graft abdominal aortic infection managed with orthotopic xeno pericardial grafts or cryopreserved allograft

Lucas Battistella, Ramla Kireche, Jean Baptiste Ricco, Thibaut Boisroux, Jason Shourick, Xavier Chaufour, Ludovic Canaud, Aurélien Hostalrich

Journal of Vascular Surgery · 2025-07 · 82 (1) · 90-101.e3

DOI: 10.1016/j.jvs.2025.03.182 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Vascular Surgery, 2025-07. Verfasst von Lucas Battistella und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, University Hospital of Rangueil, Toulouse, France. Hauptthemen laut MEDLINE: Cryopreservation, Blood Vessel Prosthesis, Pericardium, Prosthesis-Related Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The ideal substitute for in situ reconstruction of aortic graft or native aortic infection has yet to be defined. Though recognized as resistant to infection, cryopreserved arterial allograft (Allograft) presents problems of availability when treating emergent cases, with the risk of long-term aneurysmal degeneration. Commercially available bovine pericardial substitutes (Pericard) seems to be an alternative, with promising results in the recent literature. The goal of this study was to compare the results of these two substitutes. METHODS: Between January 2010 and December 2023, we conducted a retrospective observational study in two tertiary centers, including all patients having undergone in situ surgery for aortic graft or native aortic infections with reconstruction by Allograft or Pericard. Survival, reinterventions and reinfections were analyzed according to the Kaplan-Meier method and Cox regression model. RESULTS: All in all, 169 patients were included in the study with 103 aortic graft infections (60.9%), 33 aortic endograft infections (19.5%), and 33 native aortic infections (19.5%). Allograft was used in 111 patients (65.7%) and Pericard in 58 (34.3%). The two groups were comparable as regards preoperative risk factors, types of index surgery, and infectious agents, with 41 patients (24.8%) with an aortoenteric fistula. There was no significant difference in postoperative complications. The median follow-up was 18 months (interquartile range, 4-44 months). At 24 months, survival was comparable, with 68 ± 4% for Allograft and 68 ± 6 for Pericard, as was reinfection-free survival with 80 ± 4% for Allograft vs 83 ± 6% for Pericard (P = .722). Reintervention-free survival at 2 years was likewise comparable: 86 ± 4% for Allograft vs 77 ± 8% for Pericard (P = .419). CONCLUSIONS: A pericardial substitute offers the possibility of in situ aortic reconstruction without the problems of availability and with midterm results comparable with those achieved with aortic allografts. Further studies with long-term follow-up are needed to validate the absence of late reinfection and to confirm pericardial substitute patency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryopreservationBlood Vessel ProsthesisPericardiumProsthesis-Related InfectionsBlood Vessel Prosthesis ImplantationBioprosthesisAorta, AbdominalHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTreatment OutcomeTime FactorsAnimalsRisk FactorsReoperationProsthesis DesignAllograftsRisk Assessment

Stichwörter der Autor:innen

Cryopreserved allograftGraft-related aortic infectionNative aortic infectionXeno pericardial grafts

Autor:innen und Institutionen

  • Department of Vascular Surgery, University Hospital of Rangueil, Toulouse, France.
  • Department of Vascular Surgery, University Hospital of Montpellier, Montpellier, France.
  • UMR 1295 CERPOP, Inserm, Université Toulouse III - Paul Sabatier, Toulouse, France.
  • Department of Vascular Surgery, University Hospital of Rangueil, Toulouse, France. Electronic address: aurelien.hos@gmail.com.

Zitieren

APA

Battistella, L., Kireche, R., Ricco, J. B., Boisroux, T., Shourick, J., Chaufour, X., Canaud, L., & Hostalrich, A. (2025). Outcomes of native or graft abdominal aortic infection managed with orthotopic xeno pericardial grafts or cryopreserved allograft. Journal of Vascular Surgery, 82(1), 90-101.e3. https://doi.org/10.1016/j.jvs.2025.03.182

Vancouver

Battistella L, Kireche R, Ricco JB, Boisroux T, Shourick J, Chaufour X, et al. Outcomes of native or graft abdominal aortic infection managed with orthotopic xeno pericardial grafts or cryopreserved allograft. Journal of Vascular Surgery. 2025;82(1):90-101.e3. doi:10.1016/j.jvs.2025.03.182

BibTeX
@article{Battistella2025,
  author = {Battistella, Lucas and Kireche, Ramla and Ricco, Jean Baptiste and Boisroux, Thibaut and Shourick, Jason and Chaufour, Xavier and Canaud, Ludovic and Hostalrich, Aurélien},
  title = {Outcomes of native or graft abdominal aortic infection managed with orthotopic xeno pericardial grafts or cryopreserved allograft},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  volume = {82},
  number = {1},
  pages = {90--101.e3},
  doi = {10.1016/j.jvs.2025.03.182}
}
Kostenlos starten →